Unionkorea Pharm Co Ltd
080720
Company Profile
Business description
Unionkorea Pharm Co Ltd is a pharmaceutical company. The company is engaged in the development, manufacturing and marketing of brain metabolism enhancer, prescription drugs, Anti-inflammatory analgesics, and skeletal muscle relaxants.
Contact
4th Floor, 417, Samwhan-HIPEX A Tower B/D 240
Pangyoyeok-ro, Bundang-gu
Seongnam-si
Gyeonggi-do13493
KORT: +82 24893611
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
181
Stocks News & Analysis
stocks
Short-term pain for long-term gain for undervalued ASX share
Cost reductions lower our profit estimates but should lead to improved long-term outcomes.
stocks
Qantas earnings: Jetstar capitalising on weaker domestic competition
Qantas’ budget brand performing well, with segment earnings up 55%.
stocks
Nvidia Earnings: No signs of a slowdown in demand for AI chips
A selloff in Nvidia stock on the earnings news looks like a buying opportunity to us.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,010.10 | 117.10 | -1.28% |
| CAC 40 | 7,723.76 | 69.51 | 0.91% |
| DAX 40 | 23,627.49 | 140.16 | 0.60% |
| Dow JONES (US) | 45,210.14 | 85.67 | -0.19% |
| FTSE 100 | 9,159.54 | 42.85 | 0.47% |
| HKSE | 25,343.43 | 153.12 | -0.60% |
| NASDAQ | 21,545.74 | 266.11 | 1.25% |
| Nikkei 225 | 41,938.89 | 371.60 | -0.88% |
| NZX 50 Index | 13,074.81 | 58.35 | -0.44% |
| S&P 500 | 6,451.38 | 35.84 | 0.56% |
| S&P/ASX 200 | 8,738.80 | 120.20 | -1.36% |
| SSE Composite Index | 3,813.56 | 44.58 | -1.16% |